Profile data is unavailable for this security.
About the company
Yifeng Pharmacy Chain Co Ltd is a China-based company principally engaged in the chain retailing of pharmaceuticals, health products, medical equipment and health-related household convenience products. The Company mainly operates through retailing segment. The Company operates direct pharmaceutical chain stores mainly in provinces (or municipalities), including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang and Jiangxi. The retail products of the Company includes pharmaceuticals, medical equipment, health products, health food, personal care products and maternal and child products. The Company is also engaged in the wholesale business through its subsidiary, Hunan Yifeng Pharmaceutical Co., Ltd.
- Revenue in CNY (TTM)23.92bn
- Net income in CNY1.52bn
- Incorporated2008
- Employees39.65k
- LocationYifeng Pharmacy Chain Co LtdNo. 68Jinzhou Avenue, Lugu High-Tech ZoneCHANGSHA 410000ChinaCHN
- Phone+86 73 189953989
- Fax+86 73 189953989
- Websitehttp://www.yfdyf.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fangzhou Inc | 2.47bn | -862.51m | 7.07bn | 515.00 | -- | -- | -- | 2.87 | -0.6914 | -0.6914 | 1.98 | -1.60 | -- | -- | -- | 5,149,728.00 | -- | -- | -- | -- | 20.52 | -- | -34.94 | -- | 0.699 | -- | 30.75 | -- | 10.43 | -- | 48.66 | -- | -- | -- |
| MedPlus Health Services Ltd | 5.15bn | 86.01m | 7.61bn | 21.00k | 88.65 | 5.42 | 26.08 | 1.48 | 8.37 | 8.37 | 500.31 | 136.89 | 1.97 | 3.55 | 447.43 | 2,855,699.00 | 3.29 | 2.68 | 4.02 | 3.48 | 22.66 | 21.14 | 1.67 | 1.38 | 0.6598 | 1.77 | 0.3863 | 0.00 | 23.42 | 19.87 | 31.57 | 40.59 | 31.14 | -- |
| Dashenlin Pharmaceutical Group Co Ltd | 26.54bn | 850.26m | 17.42bn | 45.47k | 20.55 | 2.54 | -- | 0.6566 | 0.7445 | 0.7445 | 23.37 | 6.03 | 1.12 | 4.14 | 23.28 | 583,716.30 | 3.90 | 6.57 | 8.15 | 12.63 | 33.80 | 37.51 | 3.47 | 5.54 | 0.598 | 7.15 | 0.5981 | 45.67 | 15.45 | 22.59 | 12.63 | 17.02 | 26.51 | 6.85 |
| Welcia Holdings Co Ltd | 57.91bn | 1.03bn | 18.44bn | 15.29k | 17.70 | 1.57 | 8.56 | 0.3183 | 106.05 | 106.05 | 5,982.48 | 1,194.41 | 2.11 | 6.31 | 17.08 | 80,917,640.00 | 3.67 | 5.76 | 6.63 | 10.23 | 30.23 | 30.81 | 1.74 | 2.51 | 0.6511 | 38.94 | 0.2343 | 23.97 | 6.38 | 9.33 | -2.14 | 8.71 | 2.59 | 10.12 |
| Yifeng Pharmacy Chain Co Ltd | 23.92bn | 1.52bn | 27.35bn | 39.65k | 17.93 | 2.67 | -- | 1.14 | 1.26 | 1.26 | 19.77 | 8.46 | 0.9734 | 4.00 | 14.51 | 603,225.00 | 6.72 | 6.93 | 12.76 | 12.47 | 38.47 | 38.73 | 6.90 | 6.71 | 0.8771 | 34.97 | 0.5237 | 26.56 | 13.59 | 26.72 | 11.57 | 27.66 | 25.93 | 33.54 |
| MatsukiyoCocokara & Co | 48.72bn | 2.41bn | 39.47bn | 13.37k | 16.37 | 1.64 | 11.25 | 0.8102 | 123.90 | 123.90 | 2,504.46 | 1,240.24 | 1.47 | 4.82 | 18.12 | 77,817,220.00 | 7.30 | 6.80 | 9.56 | 8.87 | 34.85 | 33.45 | 4.98 | 4.57 | 1.21 | -- | 0.0374 | 28.65 | 7.49 | 12.16 | 29.11 | 15.90 | 29.38 | 11.10 |
| Alibaba Hlth Infrmtn Tchnlgy Ltd | 28.37bn | 1.21bn | 53.17bn | 1.42k | 42.50 | 3.48 | 42.09 | 1.87 | 0.0835 | 0.0835 | 1.98 | 1.02 | 1.36 | 12.96 | 39.09 | 21,241,820.00 | 5.79 | 1.89 | 7.62 | 2.54 | 23.15 | 21.67 | 4.26 | 1.49 | 2.11 | -- | 0.0044 | 0.00 | 0.9847 | 39.61 | 64.93 | -- | 30.14 | -- |
| JD Health International Inc | 54.82bn | 2.62bn | 81.07bn | 3.18k | 30.62 | 1.55 | 28.54 | 1.48 | 0.8915 | 0.8915 | 18.63 | 17.58 | 0.8519 | 7.84 | 157.40 | 18,888,340.00 | 4.07 | -8.61 | 5.16 | -10.70 | 22.57 | 22.76 | 4.78 | -10.39 | 3.35 | -- | 0.0042 | -- | 14.54 | 45.64 | 463.49 | 58.38 | 95.69 | -- |
Data as of Nov 25 2024. Currency figures normalised to Yifeng Pharmacy Chain Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
11.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| First Sentier Investors (Australia) IM Ltd.as of 30 Jun 2024 | 25.13m | 2.07% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 24.04m | 1.98% |
| T. Rowe Price Hong Kong Ltd.as of 30 Sep 2024 | 20.37m | 1.68% |
| First Sentier Investors (Hong Kong) Ltd.as of 31 Jul 2024 | 15.10m | 1.25% |
| FIL Investment Management (Singapore) Ltd.as of 30 Sep 2024 | 12.87m | 1.06% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 10.07m | 0.83% |
| Baillie Gifford & Co.as of 31 Oct 2024 | 8.23m | 0.68% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 8.05m | 0.66% |
| Foresight Fund Management Co., Ltd.as of 30 Sep 2024 | 7.16m | 0.59% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 6.83m | 0.56% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
